127 related articles for article (PubMed ID: 7532725)
1. The use of age-specific reference ranges for serum prostate specific antigen in men 60 years old or older.
Oesterling JE; Jacobsen SJ; Cooner WH
J Urol; 1995 Apr; 153(4):1160-3. PubMed ID: 7532725
[TBL] [Abstract][Full Text] [Related]
2. Standard versus age-specific prostate specific antigen reference ranges among men with clinically localized prostate cancer: A pathological analysis.
Partin AW; Criley SR; Subong EN; Zincke H; Walsh PC; Oesterling JE
J Urol; 1996 Apr; 155(4):1336-9. PubMed ID: 8632568
[TBL] [Abstract][Full Text] [Related]
3. Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges.
Oesterling JE; Jacobsen SJ; Chute CG; Guess HA; Girman CJ; Panser LA; Lieber MM
JAMA; 1993 Aug; 270(7):860-4. PubMed ID: 7688054
[TBL] [Abstract][Full Text] [Related]
4. The clinical usefulness of prostate-specific antigen (PSA) level and age-specific PSA reference ranges for detecting prostate cancer in Chinese.
Wu TT; Huang JK
Urol Int; 2004; 72(3):208-11. PubMed ID: 15084763
[TBL] [Abstract][Full Text] [Related]
5. The value of screening tests in the detection of prostate cancer. Part II: Retrospective analysis of free/total prostate-specific analysis ratio, age-specific reference ranges, and PSA density.
Bangma CH; Kranse R; Blijenberg BG; Schröder FH
Urology; 1995 Dec; 46(6):779-84. PubMed ID: 7502415
[TBL] [Abstract][Full Text] [Related]
6. Age specific prostate specific antigen reference ranges: population specific.
Borer JG; Sherman J; Solomon MC; Plawker MW; Macchia RJ
J Urol; 1998 Feb; 159(2):444-8. PubMed ID: 9649260
[TBL] [Abstract][Full Text] [Related]
7. Free, complexed and total serum prostate specific antigen: the establishment of appropriate reference ranges for their concentrations and ratios.
Oesterling JE; Jacobsen SJ; Klee GG; Pettersson K; Piironen T; Abrahamsson PA; Stenman UH; Dowell B; Lövgren T; Lilja H
J Urol; 1995 Sep; 154(3):1090-5. PubMed ID: 7543605
[TBL] [Abstract][Full Text] [Related]
8. Selection of optimal prostate specific antigen cutoffs for early detection of prostate cancer: receiver operating characteristic curves.
Catalona WJ; Hudson MA; Scardino PT; Richie JP; Ahmann FR; Flanigan RC; DeKernion JB; Ratliff TL; Kavoussi LR; Dalkin BL; Waters WB; MacFarlane MT; Southwick PC
J Urol; 1994 Dec; 152(6 Pt 1):2037-42. PubMed ID: 7525995
[TBL] [Abstract][Full Text] [Related]
9. Prostate cancer detection at low prostate specific antigen.
Schröder FH; van der Cruijsen-Koeter I; de Koning HJ; Vis AN; Hoedemaeker RF; Kranse R
J Urol; 2000 Mar; 163(3):806-12. PubMed ID: 10687982
[TBL] [Abstract][Full Text] [Related]
10. Age-related reference levels of serum prostate-specific antigen among Taiwanese men without clinical evidence of prostate cancer.
Lin KJ; Pang ST; Chang YH; Wu CT; Chuang KL; Chuang HC; Chuang CK
Chang Gung Med J; 2010; 33(2):182-7. PubMed ID: 20438671
[TBL] [Abstract][Full Text] [Related]
11. Comparison of different prostate-specific antigen cutpoints for early detection of prostate cancer: results of a large screening study.
Reissigl A; Pointner J; Horninger W; Ennemoser O; Strasser H; Klocker H; Bartsch G
Urology; 1995 Nov; 46(5):662-5. PubMed ID: 7495117
[TBL] [Abstract][Full Text] [Related]
12. Age-specific reference ranges for PSA in the detection of prostate cancer.
DeAntoni EP
Oncology (Williston Park); 1997 Apr; 11(4):475-82, 485; discussion 485-6, 489. PubMed ID: 9130271
[TBL] [Abstract][Full Text] [Related]
13. Percent free prostate specific antigen in the total prostate specific antigen 2 to 4 ng./ml. range does not substantially increase the number of biopsies needed to detect clinically significant prostate cancer compared to the 4 to 10 ng./ml. range.
Haese A; Dworschack RT; Partin AW
J Urol; 2002 Aug; 168(2):504-8. PubMed ID: 12131298
[TBL] [Abstract][Full Text] [Related]
14. Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurements.
Catalona WJ; Smith DS; Ornstein DK
JAMA; 1997 May; 277(18):1452-5. PubMed ID: 9145717
[TBL] [Abstract][Full Text] [Related]
15. Prostate cancer screening within a prostate specific antigen range of 3 to 3.9 ng./ml.: a comparison of digital rectal examination and free prostate specific antigen as supplemental screening tests.
Mäkinen T; Tammela TL; Hakama M; Stenman UH; Rannikko S; Aro J; Juusela H; Määttänen L; Auvinen A
J Urol; 2001 Oct; 166(4):1339-42. PubMed ID: 11547069
[TBL] [Abstract][Full Text] [Related]
16. Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower.
Thompson IM; Ankerst DP; Chi C; Lucia MS; Goodman PJ; Crowley JJ; Parnes HL; Coltman CA
JAMA; 2005 Jul; 294(1):66-70. PubMed ID: 15998892
[TBL] [Abstract][Full Text] [Related]
17. Are age-specific reference ranges for prostate specific antigen population specific?
Wolff JM; Brehmer B; Borchers H; Rohde D; Jakse G
Anticancer Res; 2000; 20(6D):4981-3. PubMed ID: 11326652
[TBL] [Abstract][Full Text] [Related]
18. Significance of serum free prostate specific antigen in the screening of prostate cancer.
Higashihara E; Nutahara K; Kojima M; Okegawa T; Miura I; Miyata A; Kato M; Sugisaki H; Tomaru T
J Urol; 1996 Dec; 156(6):1964-8. PubMed ID: 8911366
[TBL] [Abstract][Full Text] [Related]
19. Age specific reference levels of serum prostate-specific antigen, prostate volume and prostate specific antigen density in healthy Iranian men.
Khezri AA; Shirazi M; Ayatollahi SM; Lotfi M; Askarian M; Ariafar A; Afrasiabi MA
Iran J Immunol; 2009 Mar; 6(1):40-8. PubMed ID: 19293477
[TBL] [Abstract][Full Text] [Related]
20. Potential effects of age-specific reference ranges for serum prostate-specific antigen.
Lankford SP; Peters KL; Elser RC
Eur Urol; 1995; 27(3):182-6. PubMed ID: 7541357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
